4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

NCT03538743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Placebo
DRUG: PF-06882961
DRUG: PF-06882961
DRUG: PF-06882961
DRUG: PF-06882961
DRUG: PF-06882961
DRUG: PF-06882961
DRUG: PF-06882961
DRUG: PF-06882961

Sponsor

Pfizer